BioNTech returns to profit in the third quarter and raises the lower end of its 2026 revenue guidance
German biotechnology company BioNTech reported a net profit of €184.5 million in the third quarter, against a loss a year earlier, and raised the lower end of its 2026 revenue guidance to €1.7 billion. However, its loss for the first nine months of the year widened.
Otabek Yusupov